Poster Theater Flash Session
Nutritional Immunology and Inflammation
Advanced Glycation End Products, (AGEs) and their soluble receptor (sRAGE) have been implicated in the development of complications and mortality among individuals with type 2 diabetes (T2D). There is limited information on the relationship between AGEs and sRAGE and risk of cardiovascular diseases (CVD) in minority groups, who have a higher burden of T2D. The relationship between AGEs and sRAGE and CVD risks in adults with T2D and vitamin D insufficiency/deficiency was assessed in a minority population.
A cross sectional study of Hispanics and African Americans with T2D ( n=64, 41 women and 23 men, mean age= 54 ± 9) recruited from two clinics in Miami Dade. Systolic (SBP) and diastolic blood pressure (DBP), weight and height measurement and serum lipid profile were completed. ELISA kits were used to assess serum levels of AGEs (Biotang Inc/TSZ Elisa, Waltham, MA, USA) and sRAGE (Biotang Inc/TSZ Elisa, Waltham, MA, USA). Multiple linear regression was used to assess association between AGEs, sRAGE and CVD risks.
Results : A negative and significant association between AGEs and high-density lipoprotein cholesterol (HDL-C)(B = -0.551, P=0.029) was found. The relationship between AGEs and HDL-C persisted after adjusting for covariates (P< 0.05). sRAGE was significantly associated with SBP (B = 0.015, P=0.025) and diastolic blood pressure DBP (B = 0.0271, P=0.037). Results loss significance when association between sRAGE and DBP and SBP were adjusted for covariates such as age, body mass index (BMI), smoking and alcohol intake.
Our results suggest that AGEs and sRAGE are related to markers of cardiovascular risk such as HDL-C, SBP and DBP in the study population of African Americans and Hispanics with T2D and vitamin D insufficiency/deficiency. Measures on reducing serum levels of AGEs and improving sRAGE and vitamin D are warranted in these populations for risk reduction of CVD.
Funding Sources :
Partial funding for this research was provided through an NIH/NIDDK sponsored grant.